MedTrace Logo

Multiparametric Ultrasound-Study for the Detection of Prostate Cancer

NCT03091231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-04-12

No results posted yet for this study

Summary

The primary objective of the study is the matching of sensitivity, specificity, the negative predicate value and the positive predictive value of Contrast-Enhanced Ultrasound (CEUS), Shear Wave Elastography (SWE) and the combination to detect clinically significant prostate carcinoma foki.

Conventional ultrasound is insufficient to safely display prostate carcinoma. Therefore, other imaging agents are recently added to improve the detection of tumor foci. These include innovative imaging ultrasound methods and multiparametric MRI.

Conditions

Interventions

DIAGNOSTIC_TEST

mpUS multiparametric Ultrasound

compare the mpUS to other methods

Sponsors & Collaborators

  • Eindhoven University of Technology

    collaborator OTHER

  • Martini-Klinik am UKE GmbH

    lead OTHER

Principal Investigators

  • Georg Salomon, PD Dr. · Martini-Klinik am UKE GmbH

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03091231 on ClinicalTrials.gov